Cargando…
Identification of a genetic variant associated with treatment outcome in ovarian cancer: the potential role of cholesterol metabolism as a determinant of response to chemotherapy
Autores principales: | Chenevix-Trench, Georgia, Lu, Yi, Johnatty, Sharon, Gamazon, Eric, Beesley, Jonathan, Chen, Xiaoqing, Gao, Bo, Harnett, Paul, Stephanie Huang, R, Despierre, Evelyn, Heitz, Florian, Hogdall, Estrid, Hogdall, Claus, Brown, Robert, Moyisch, Kirsten, Fasching, Peter, Goode, Ellen, Russell, Amanda, Henderson, Michelle, Haber, Michelle, Dolan, Eileen, Macgregor, Stuart, deFazio, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3327169/ http://dx.doi.org/10.1186/1897-4287-10-S2-A36 |
Ejemplares similares
-
Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer
por: Gao, Bo, et al.
Publicado: (2014) -
Organoids and epithelial ovarian cancer - a future tool for personalized treatment decisions? (Review)
por: Sisman, Yagmur, et al.
Publicado: (2022) -
Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer
por: French, Juliet D., et al.
Publicado: (2016) -
Searching for new biomarkers in ovarian cancer patients: Rationale and design of a retrospective study under the Mermaid III project
por: Hentze, Julie L., et al.
Publicado: (2017) -
Next Generation Sequencing Technology in the Clinic and Its Challenges
por: Vestergaard, Lau K., et al.
Publicado: (2021)